ColgatePalmolive (CL)
(Delayed Data from NYSE)
$92.57 USD
+1.80 (1.98%)
Updated Nov 8, 2024 04:00 PM ET
After-Market: $92.61 +0.04 (0.04%) 6:56 PM ET
3-Hold of 5 3
D Value A Growth C Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$92.57 USD
+1.80 (1.98%)
Updated Nov 8, 2024 04:00 PM ET
After-Market: $92.61 +0.04 (0.04%) 6:56 PM ET
3-Hold of 5 3
D Value A Growth C Momentum C VGM
Zacks News
Top Research Reports for Vale, ConocoPhillips & Colgate-Palmolive
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including ConocoPhillips (COP), Colgate-Palmolive (CL), and Vale (VALE).
Top Research Reports for Netflix, Goldman Sachs & Kinder Morgan
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Netflix, Inc. (NFLX), Kinder Morgan Inc (KMI) and The Goldman Sachs Group Inc (GS).
Top Research Reports on Wells Fargo, Altria and Dow
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Wells Fargo (WFC), Altria (MO) and Dow Chemical (DOW).
Can Colgate's (CL) Dividend Hike Help Boost Stock Further?
by Zacks Equity Research
Keeping up with this trend, Colgate-Palmolive (CL) hiked its quarterly dividend. Through these dividend increases companies persuade investors to either buy or hold the scrip instead of selling it.
Colgate-Palmolive (CL) Up 7.5% Since Earnings Report: Can It Continue?
by Zacks Equity Research
Colgate-Palmolive (CL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Colgate (CL) Q4 Earnings In Line, Revenues Lag; Stock Down
by Zacks Equity Research
Colgate-Palmolive Co. (CL) posted in-line earnings in fourth-quarter 2016, maintaining its trend of beating and meeting estimates in alternate quarters for the sixth straight time.
Colgate (CL) Q4 Earnings in Line, Stock Down as Sales Miss
by Zacks Equity Research
Colgate (CL) came out with fourth-quarter 2016 results.
Procter & Gamble (PG) Beats on Q2 Earnings, Updates View
by Zacks Equity Research
The Procter & Gamble Company's (PG), popularly known as P&G, second-quarter fiscal 2017 earnings and revenues exceeded expectations.
Top Research Reports for December 29, 2016
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Wells Fargo (WFC), Danaher (DHR) and Colgate-Palmolive (CL).
Top Research Reports for Boeing, GM, UnitedHeal
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Boeing (BA), General Motors (GM), UnitedHealth (UNH) and Honeywell (HON).
Top 7 Research Reports for July 15, 2016
by Sheraz Mian
Today's must-read reports are for Boeing (BA), Kellogg (K) and Colgate (CL).